Microarray Analysis Market Size

Global Microarray Analysis Market Overview

Microarray Analysis Market Size was valued at USD 2.8 Billion in 2023. The microarray analysis market industry is projected to grow from USD 3.02 Billion in 2024 to USD 5.3 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 7.24% during the forecast period (2024 - 2032).Increased cancer incidence and the expanding demand for pharmaceutical industry research are the key market drivers enhancing market growth. The market has been propelled by the rising incidence of various chronic diseases, the use of this approach to diagnose infectious diseases, advancements in genetics, and rising healthcare costs.

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Microarray Analysis Market Trends

• Increasing applications of microarray analysis are driving market growth.

The major factor projected to fuel market expansion over the forecast period is the increase in the use of microarrays in various applications. For instance, using microarray analysis in antibiotic therapy has shown to be successful since, in most cases, bacterial genomic DNA outlives the survival of bacteria. A DNA microarray is typically employed in these situations since a diagnosis may be made with a tiny bit of DNA rather than more bacteria required for culturing. The preferred technique for determining gene expression has recently been using DNA-based microarrays. This is mostly attributable to complexity reduction and cost-cutting, making technology more widely available and uniform. Thus, driving the microarray analysis market revenue.

Products that can assist patients with a wide range of applications have been developed due to advancements in diagnosis and treatment options. Genomic Medicine in Emerging Economies, a book released in 2018, shows how improvements in patient care have already been made in populations like Indonesia, Chile, Malaysia, Argentina, China, Sri Lanka, and Colombia due to medical research advancements. Major companies, like Thermo Fisher Scientific Inc., Agilent Technologies Inc., Illumina, and Bio-Rad Laboratories, Inc., have recently introduced new goods due to the changing external business climate brought on by the rising demand from researchers and doctors.

The expansion of the microarray analysis market needs to be improved by the availability of alternatives and other analysis mediums. For instance, microarray analysis only uses hybridization to profile specific transcripts and genes, whereas RNA sequencing enables complete sequencing of the entire transcriptome. Additionally, the need for database standardization and more qualified personnel are two other issues impeding the market's expansion.

Microarray Analysis Market Segment Insights

Microarray Analysis Product & Services Insights

Based on the product and services, the  microarray analysis market segmentation includes consumables, software and services. The consumables sector is anticipated to hold the greatest market share for microarray analysis in 2022. The expanding use of microarray in numerous fields and the frequent, recurring, and large-scale consumable procurement are responsible for this segment's significant market share. Slides, functionalized glass, plastic, and functionalized cover slides are consumables for the microarrays. These consumables are utilized for the gene scanning processes employed in microarray technology. The demand for consumables has increased as a result of an increase in the number of diagnostic laboratories and research facilities. Furthermore, the use of consumables for microarrays has increased due to increased DNA methylation and mRNA investigations.

Microarray Analysis Type Insights

Based on type, the microarray analysis market segmentation includes DNA microarrays and protein microarrays. The market for microarray analysis is anticipated to be dominated by DNA microarrays. The significant market share of this sector can be attributable to the numerous uses of DNA microarrays, including drug discovery, genomic and cancer research, personalized medicine, and the diagnosis of genetic diseases.

Figure 1 Microarray Analysis Market, by Type, 2023 & 2032 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Microarray Analysis Application Insights

Based on application, the microarray analysis market segmentation includes drug discovery, disease diagnostic and research applications. The research applications category will hold the greatest market share. The main driver of this industry is the rise in public and private financing for genomic and proteomic research.

Microarray Analysis End User Insights

Based on end-user, the microarray analysis market segmentation includes research and academic institutes, pharmaceutical and biotechnology companies, and diagnostic laboratories. The greatest market share of this market is anticipated to be held by academic and research institutions. Growing government funding and support for genomics research projects is a major element fueling the research and academic sector expansion.

Microarray Analysis Regional Insights

By region, the study provides market insights into North America, Europe, Asia-Pacific and the Rest of the World. North America leads the market, followed by Europe. The US and Canada make up the North American market. The market for microarray analysis in North America is expanding due to factors such as the rising incidence of cancer and increased financing for research and development in this area. For instance, the National Institute of Cancer got funds for cancer research of about USD 42.1 in 2019. Microarrays are employed in the detection of cancer cells and the analysis of cellular genetic makeup. Additionally, the increased funding for proteomics and genomics due to the rise in the demand for new medications has contributed to the expansion of the microarray analysis industry.

Further, the major countries studied in the market report are The US, Canada, German, France, the UK, Italy, Spain, China, Japan, India, Australia, South Korea, and Brazil.

Figure 2 MICROARRAY ANALYSIS MARKET SHARE BY REGION 2023 (USD Billion)

Source Secondary Research, Primary Research, MRFR Database and Analyst Review

Europe's microarray analysis market accounts for the second-largest market share. Further, the German microarray analysis market held the largest market share, and the UK was the fastest-growing market in the European region.

The Asia Pacific microarray analysis Market, is expected to grow at the fastest CAGR from 2024 to 2032. Moreover, China’s microarray analysis market held the largest market share, and the Indian microarray analysis market was the fastest-growing market in Asia.

Microarray Analysis Key Market Players & Competitive Insights

Leading industry companies are making significant R&D investments to diversify their product offerings, which will spur further expansion of the market for microarray analysis. Market participants also engage in various strategic actions to increase their worldwide footprint. Important market developments include introducing new products, contractual agreements, mergers and acquisitions, increased investments, and collaboration with other organizations. To grow and thrive in a more cutthroat and competitive market environment, the casein & casein derivatives sector must provide affordable products.

One of the main business strategies manufacturers use in the worldwide microarray analysis industry to benefit customers and expand the market sector is local manufacturing to reduce operational costs. The microarray analysis sector has recently provided some of the most important medicinal benefits. Major players in the microarray analysis market include Agilent Technologies (US), Bio-Rad Laboratories (US), Illumina (US), Thermo Fisher Scientific (US), Microarrays, Inc. (US), PerkinElmer, Inc. (US), Merck KGaA (Germany), GE Healthcare (US), Danaher Corporation (US), Arrayit Corporation (US), and others.

With its  headquarters in Santa Clara, California, Agilent Technologies, Inc. offers instruments, software, services, and consumables for labs. Hewlett-Packard created Agilent as a spin-off in 1999. The Agilent stock IPO that followed was the biggest in Silicon Valley history. The business developed optics (LED, laser), semiconductors, EDA software, and test and measurement tools for electronics between 1999 and 2014; this segment was sold off to create Keysight. Since then, the business has kept growing by entering the pharmaceutical, clinical diagnostics, and academic and government (research) markets.

The American business Bio-Rad Laboratories, Inc. develops and manufactures specialized technological products for the clinical diagnostics and life science research markets. The company was started in 1952 in Berkeley, California, by Alice and David, a couple who attended the University of California, Berkeley. Bio-Rad is based in Hercules, California, and has offices worldwide. Most of Bio-Rad's life science offerings include software, consumables, instruments, reagents, and content for cell biology, protein quantitation, drug discovery and production, food safety, and scientific education. These goods are based on technology that can separate, purify, identify, analyze, and amplify biological materials like bacteria, cells, and nucleic acids. The diagnostic systems and products from Bio-Rad employ various technologies and offer clinical data in the markets for autoimmune, infectious disease testing, blood transfusion, and monitoring diabetes. These goods support the diagnosis, observation, and treatment of illnesses and other medical situations.

Key Companies in the microarray analysis market include

• Agilent Technologies (US)


• Bio-Rad Laboratories (US)


• Illumina (US)


• Thermo Fisher Scientific (US)


• Microarrays, Inc. (US)


• PerkinElmer, Inc. (US)


• Merck KGaA (Germany)


• GE Healthcare (US)


• Danaher Corporation (US)


• Arrayit Corporation (US)

Microarray Analysis Industry Developments

August 2019 Lionheart Technologies LLC ("BioTek"), a renowned  leader in the production, design, and sale of cutting-edge life science instruments, was purchased by Agilent Technologies, Inc. Cell imaging systems, microplate readers, washers, dispensers, automated incubators, and stackers are among its wide range of products.

September 2018 To offer complete single nucleotide polymorphism (SNP) assay development, Novacyt Group cooperated with Applied Microarrays, Inc. on the production of point-of-care (POC) and high throughput DNA and protein arrays as well as customized microarrays.

Microarray Analysis Market Segmentation

Microarray Analysis Products & Services Outlook

• Consumables


• Software and Services


• Instruments

Microarray Analysis Application Outlook

• Drug Discovery


• Disease Diagnostics


• Research Applications

Microarray Analysis Type Outlook

• DNA Microarrays


• Protein Microarrays

Microarray Analysis End User Outlook

• Research & Academic Institutes


• Pharmaceutical & Biotechnology Companies


• Diagnostic Laboratories

Microarray Analysis Regional Outlook

• North America
  
  
  
  • US
  
  
  • Canada
  
  
  
  


• Europe
  
  
  
  • Germany
  
  
  • France
  
  
  • UK
  
  
  • Italy
  
  
  • Spain
  
  
  • Rest of Europe
  
  
  
  


• Asia-Pacific
  
  
  
  • China
  
  
  • Japan
  
  
  • India
  
  
  • Australia
  
  
  • South Korea
  
  
  • Australia
  
  
  • Rest of Asia-Pacific
  
  
  
  


• Rest of the World
  
  
  
  • Middle East
  
  
  • Africa
  
  
  • Latin America